RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.

Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes.

Add to Collection
2010 Aug Others Fist_Author_Year_PM

Full Author : ['Sharma, Bhupesh', 'Singh, Nirmal']
Journal Title : Current neurovascular research
Chapter : Section3
Journal Year : 2010
Cited by : Not Available

Diabetes has been found to increase the probability of vascular dementia in humans. We have investigated the effect of 4'-hydroxy-3'-methoxyacetophenone (HMAP), a NADPH oxidase inhibitor and Pitavastatin, HMG Co-A reductase inhibitor, on Streptozotocin (S.....

Keywords : ["hmap reduce cognitive dysfunction", "vascular dementia", "experimental diabetes", "pitavastatin"]